Federal prosecutors said last week that Spiracur agreed to pay $3 million to settle charges that it paid kickbacks to U.S. Veterans Affairs Dept. physicians in return for using the Snap negative pressure wound therapy it just sold to Acelity. Sunnyvale, Calif.-based Spiracur admitted no wrongdoing in the settlement, but agreed to cooperate with the […]
Spiracur
Acelity acquires Snap wound treatment from Spiracur
Acelity, looking to accelerate its plans for a disposable negative-pressure wound therapy, said today that it acquired the Snap portable NPWT device from Spiracur for an undisclosed amount. San Antonio, Texas-based Acelity, which is preparing for an initial public offering that could fetch up to $1 billion, said the Snap system is designed to treat hard-to-heal wounds […]
Vascular Dynamics reports raising $10 million in funding round | Medtech funding for the week of November 10, 2014
Spiracur raises $16m from GE Capital
Spiracur said today that it raised $16 million debt round from GE Capital for its negative-pressure wound therapy device.
Sunnyvale, Calif.-based Spiracur said it plans to use the proceeds to launch new products, penetrate new care settings and for global expansion.
Spiracur wins reimbursement for SNaP wound care
California device maker Spiracur won reimbursement coverage from insurance giant Health Care Services Corp., covering the SNaP wound care system.
Ex-Neuronetics, Abiomed exec is Intact Vascular’s new CEO | Personnel Moves
Intact Vascular said yesterday that it named medical device veteran Bruce Shook as its new president & CEO.
Spiracur wins 2 Medicare reimbursement codes for its wound care systems
Medtech maker Spiracur was awarded 2 new Medicare reimbursement codes for its negative-pressure SNaP wound care system, a device which aims to help physicians heal wounds more rapidly for their patients.
The HCPCS codes G0456 and G0457, which were issued from the Centers for Medicare & Medicaid Services, are for clinical services using a mechanically-powered device, providing an effective, off-the-shelf solution for negative pressure wound therapy, Spiracur said.
